In a study by Nasirinezhad and team, FAAH inhibition significantly attenuated persistent pain-related behaviors in a rat model of human immunodeficiency virus (HIV) sensory neuropathy, suggesting that FAAH inhibitors could be beneficial for managing pain in diverse clinical contexts [105]. This evidence concerns the gene FAAH and sensory peripheral neuropathy.